RAPP FY 2023 Earnings — Rapport Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

RAPPRapport Therapeutics, Inc. Common Stock

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$112,000

Operating Income

-$36M

Net Income

-$35M

EPS (Diluted)

$-0.19

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$29M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$155M

Total Liabilities

$181M

Stockholders' Equity

-$26M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$112,000	-$15,000	-646.7%
Operating Income	-$36M	-$10M	-249.0%
Net Income	-$35M	-$11M	-226.6%